<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Are Generics Just as Good?</title>
	<atom:link href="http://healthblog.ncpa.org/are-generics-just-as-good/feed/" rel="self" type="application/rss+xml" />
	<link>http://healthblog.ncpa.org/are-generics-just-as-good/</link>
	<description>Health Care Policy and Reform Insights &#124; NCPA</description>
	<lastBuildDate>Mon, 21 May 2012 13:39:13 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
	<item>
		<title>By: Linda Gorman</title>
		<link>http://healthblog.ncpa.org/are-generics-just-as-good/comment-page-1/#comment-37681</link>
		<dc:creator>Linda Gorman</dc:creator>
		<pubDate>Mon, 28 Apr 2008 16:31:36 +0000</pubDate>
		<guid isPermaLink="false">http://www.john-goodman-blog.com/are-generics-just-as-good/#comment-37681</guid>
		<description>In cases where drugs have a narrow therapeutic index, generic substitution has been a problem for some time. Participants at a 2001 American Society of Transplantation conference were so concerned about the effects of forced switching from brand to generic immunosuppressive drugs that they called for patients to be educated to inform their physicians of any switch to or among generic alternatives. 

Other cases in which compulsory generic substitution clearly causes problems include epilepsy and tacharrhythmia. Finally, it turns out that a lot of people have no idea how much variation there can be in a generic that meets FDA requirements. Biologics pose a much more difficult problem.

Like so many things in health care, the wisdom of compulsory generic substitution isn&#039;t as simple as those pounding the table about waste in medicine would have one believe.</description>
		<content:encoded><![CDATA[<p>In cases where drugs have a narrow therapeutic index, generic substitution has been a problem for some time. Participants at a 2001 American Society of Transplantation conference were so concerned about the effects of forced switching from brand to generic immunosuppressive drugs that they called for patients to be educated to inform their physicians of any switch to or among generic alternatives. </p>
<p>Other cases in which compulsory generic substitution clearly causes problems include epilepsy and tacharrhythmia. Finally, it turns out that a lot of people have no idea how much variation there can be in a generic that meets FDA requirements. Biologics pose a much more difficult problem.</p>
<p>Like so many things in health care, the wisdom of compulsory generic substitution isn&#8217;t as simple as those pounding the table about waste in medicine would have one believe.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: John Goodman</title>
		<link>http://healthblog.ncpa.org/are-generics-just-as-good/comment-page-1/#comment-37677</link>
		<dc:creator>John Goodman</dc:creator>
		<pubDate>Mon, 28 Apr 2008 15:16:54 +0000</pubDate>
		<guid isPermaLink="false">http://www.john-goodman-blog.com/are-generics-just-as-good/#comment-37677</guid>
		<description>&lt;p&gt;The &lt;em&gt;Wall Street Journal&lt;/em&gt; has published two Letters to the Editor in response to this topic.&lt;/p&gt; &lt;p&gt;See &lt;a href=&quot;http://www.john-goodman-blog.com/wp-content/uploads/Generics%20Not%20Same.pdf&quot; rel=&quot;nofollow&quot;&gt;here&lt;/a&gt;.&lt;/p&gt;</description>
		<content:encoded><![CDATA[<p>The <em>Wall Street Journal</em> has published two Letters to the Editor in response to this topic.</p>
<p>See <a href="http://www.john-goodman-blog.com/wp-content/uploads/Generics%20Not%20Same.pdf" rel="nofollow">here</a>.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

